JAK2 and acute lymphoblastic leukemia: The abnormalities of the Jak2-Stat5 pathway are frequent in Ph-like ALL; however, although most of the Ph-like patients (80%) do not present Abl type fusions, it is important to detect Abl positive cells since they are sensitive to currently available tyrosine kinase inhibitors (TKIs) [10].